Max Healthcare Institute Ltd Share Price
(MAXHEALTH)
₹980.75
as on 04:01PM, 07 Mar 2025
Max Healthcare Institute Ltd Performance
Day's Low
Day's High
₹977.15Day's Price Range₹1,012.752 Week's Low
52 Week's High
₹719.4552-Week Price Range₹1,227.95
| Returns % | |
| 1 Month Return | -8.5 % |
| 3 Month Return | -12.19 % |
| 1 Year Return | + 28.1 % |
| Market Stats | |
| Previous Close | ₹999.90 |
| Open | ₹1,004.90 |
| Volume | 13.24L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹95,342.83Cr |
Max Healthcare Institute Ltd Key Statistics
P/E Ratio
94.48
PEG Ratio
-188.97
Market Cap
₹95,342.83 Cr
P/B Ratio
10.38
EPS
10.88
Dividend Yield
0.18
Sector
Healthcare
ROE
9.34
Max Healthcare Institute Ltd Mutual Fund Holdings
Max Healthcare Institute Ltd Analyst Rating
based on 22 analysts
63.64%
Buy
18.18%
Hold
18.18%
Sell
Based on 22 analysts offering long term price targets for Max Healthcare Institute Ltd. An average target of ₹1151.14
Source: S&P Global Market Intelligence
Max Healthcare Institute Ltd Share analysis
Max Healthcare Institute Ltd price forecast by 22 analysts
Upside of17.37%
High
₹1390
Target
₹1151.14
Low
₹615
Max Healthcare Institute Ltd target price ₹1151.14, a slight upside of 17.37% compared to current price of ₹980.75. According to 22 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Max Healthcare Institute Ltd revenue growth forecast
Expected growth rate Q1, FY2027:125.92%
Forecast
Actual
Including amortisation and stock based compensations
Max Healthcare Institute Ltd EPS growth forecast
EPS estimate Q1, FY2027:121.23%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Max Healthcare Institute Ltd
Max Healthcare Reports Mixed Financial Performance - 04 Mar, 2025
Max Healthcare Institute Limited's revenue rose by 39.93% to Rs. 1,868 crore in Q3 FY25, while net profit fell by 17.30% to Rs. 239 crore. Shares traded down 2.74% at Rs. 946.55.Max Healthcare Reports Strong Q3 Performance - 03 Mar, 2025
Max Healthcare's Q3FY25 results show a 34.9% YoY revenue growth to INR22.7 billion, with EBITDA rising 32.7% YoY to INR6.2 billion. The company plans to enhance growth with a new 500-bed hospital in Thane by CY28.Jefferies Recommends Max Healthcare as Top Pick - 26 Feb, 2025
Jefferies has a Buy rating on Max Healthcare, setting a target price of Rs 1,380. They suggest that any weakness in hospital stocks should be viewed as a buying opportunity.Max Healthcare Director Resignation Announced - 19 Feb, 2025
Max Healthcare Institute reported the resignation of Rakesh Kaushik, Director of Legal and Regulatory Affairs, effective at the end of March 28, 2025.Max Healthcare Upgraded by UBS, Shares Surge - 18 Feb, 2025
UBS upgraded Max Healthcare to 'Buy', raising the target price to ₹1,200, citing strong growth potential. Despite a 17.4% decline in net profit, revenue increased by 39.9%. Shares gained over 3%, marking a positive trend fueled by the upgrade and expansion plans.Max Healthcare Reports Strong Q3FY25 Performance - 13 Feb, 2025
Max Healthcare, India's second-largest healthcare chain, reported a 40% YoY revenue increase to ₹1,868 crore in Q3FY25. EBITDA rose 29.3% YoY to ₹499 crore, though net profit declined 17% YoY to ₹238 crore due to a one-time expense. The company aims to double its bed capacity in the next 4-5 years through various growth strategies.Max Healthcare Faces Pressure After Q3 Results - 12 Feb, 2025
Max Healthcare shares experienced block trades worth over Rs 321 crore, with a nearly 12% decline over five days. The stock's recent pressure follows a 6.5% year-on-year drop in profit after tax for Q3 FY25, attributed to a one-time payment related to shareholding changes. Despite this, gross revenue rose to Rs 2,381 crore from Rs 1,779 crore a year ago.Max Healthcare Maintains BUY Rating with Revised Target - 03 Feb, 2025
Prabhudas Lilladher maintains a BUY rating for Max Healthcare Institute, raising the target price to Rs 1,300/share. The company shows strong EBITDA growth and expansion plans, expecting significant growth momentum through 2027.
Insights on Max Healthcare Institute Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, MAXHEALTH stock has moved up by 13.3%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MAXHEALTH has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 1.38K Cr → 1.90K Cr (in ₹), with an average increase of 7.7% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 11.56% to 11.72% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 63.2% return, outperforming this stock by 29.9%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 23.74% of holdings in Dec 2024 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 281.81 Cr → 238.8 Cr (in ₹), with an average decrease of 15.3% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 57.29% to 56.93% in Dec 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 3.83% to 3.77% in Dec 2024 quarter
Max Healthcare Institute Ltd Financials
Index Inclusions
Max Healthcare Institute Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 23.74% | 0.00 | |
| Foreign Institutions | 56.93% | ||
| Mutual Funds | 11.72% | 1.43 | |
| Retail Investors | 3.77% | ||
| Others | 3.83% | 7.03 |
Max Healthcare Institute Ltd Key Indicators
Max Healthcare Institute Ltd Valuation
Max Healthcare Institute Ltd in the last 5 years
Lowest (-108.44x)
June 23, 2021
Industry (94.31x)
March 7, 2025
Today (94.48x)
March 7, 2025
Highest (116.44x)
January 9, 2025
Max Healthcare Institute Ltd Earnings and Dividends
Max Healthcare Institute Ltd Earnings Results
Max Healthcare Institute Ltd’s net profit fell -17.47% since last year same period to ₹238.80Cr in the Q3 2024-2025. On a quarterly growth basis, Max Healthcare Institute Ltd has generated -15.26% fall in its net profits since last 3-months.
Read More about Earnings ResultsMax Healthcare Institute Ltd Dividends May,2024
In the quarter ending March 2024, Max Healthcare Institute Ltd has declared dividend of ₹1.50 - translating a dividend yield of 0.15%.
Read More about Dividends
Max Healthcare Institute Ltd Technicals Summary
Bearish
Neutral
Bullish
Max Healthcare Institute Ltd is currently in a Bearish trading position according to technical analysis indicators.
Max Healthcare Institute Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹95,342.83 Cr | 155.53% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹47,524.62 Cr | 67.52% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹89,377.98 Cr | 55.76% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
| BUY | ₹32,006.99 Cr | 79.47% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹20,507.12 Cr | 31.41% | 0.58 | ₹336 Cr | ₹2,498 Cr |
About Max Healthcare Institute Ltd
Max Healthcare Institute Ltd is one of the top healthcare providers in India, offering a wide range of products and services. Its top products include diagnostic services, medical imaging, laboratory testing, and surgical services. The company also offers a range of popular brands such as Max Super Specialty Hospital, Max Multi Specialty Centre, Max Smart Super Specialty Hospital, and Max Healthcare.
Share Price: ₹980.75 per share as on 07 Mar, 2025 04:01 PM
Market Capitalisation: ₹95,342.83Cr as of today
Revenue: ₹1,868.31Cr as on December 2024 (Q4 24)
Net Profit: ₹238.80Cr as on December 2024 (Q4 24)
Listing date: 20 Aug, 2020
Chairperson Name: Abhay Soi
| Organisation | Max Healthcare Institute Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
FAQs on Max Healthcare Institute Ltd
What is Max Healthcare Institute Ltd price today?
Max Healthcare Institute Ltd share price today stands at ₹980.75, Open: ₹1004.9, Previous Close: ₹999.9, High: ₹1012.7, Low: ₹977.15, 52 Week High: ₹1227.95, 52 Week Low: ₹719.45.
How to Buy Max Healthcare Institute Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Max Healthcare Institute Ltd shares
Is Max Healthcare Institute Ltd listed on NSE?
Max Healthcare Institute Ltd is listed on NSE
Is Max Healthcare Institute Ltd listed on BSE?
Max Healthcare Institute Ltd is listed on BSE
What are today's High and Low prices of Max Healthcare Institute Ltd?
- Today's highest price of Max Healthcare Institute Ltd is ₹1012.7.
- Today's lowest price of Max Healthcare Institute Ltd is ₹977.15.
What are today's traded volumes of Max Healthcare Institute Ltd?
Today's traded volume of Max Healthcare Institute Ltd(MAXHEALTH) is 13.24L.
What is today's market capitalisation of Max Healthcare Institute Ltd?
Today's market capitalisation of Max Healthcare Institute Ltd(MAXHEALTH) is ₹95342.83Cr.
What is the 52 Week High and Low Range of Max Healthcare Institute Ltd?
How much percentage Max Healthcare Institute Ltd is down from its 52 Week High?
Max Healthcare Institute Ltd (MAXHEALTH) share price is ₹980.75. It is down -20.13% from its 52 Week High price of ₹1227.95
How much percentage Max Healthcare Institute Ltd is up from its 52 Week low?
Max Healthcare Institute Ltd (MAXHEALTH) share price is ₹980.75. It is up 36.32% from its 52 Week Low price of ₹719.45
What are the historical returns of Max Healthcare Institute Ltd?
What is the PE ratio of Max Healthcare Institute Ltd today?
PE Ratio of Max Healthcare Institute Ltd is 94.48
PE ratio = Max Healthcare Institute Ltd Market price per share / Max Healthcare Institute Ltd Earnings per share